AUS
NZ
UK
CA
USA
IND
Healt
FDA Boosts Neuren Pharmaceuticals (ASX:NEU) with Rare Pediatric Designation
February 24, 2025 01:14 PM AEDT| By Team Kalkine MediaHighlights:,FDA grants rare pediatric designation.,Neuren,Pharmaceuticals (,ASX:NEU,) posts notable gains.,PRV program opens potential new opportunities.,In a remarkable morning session on the ASX 200, Neuren Pharmaceuticals (ASX:NEU) marked a signif...
Regis Healthcare's Remarkable Turnaround and Expansion Strategy
February 24, 2025 12:59 PM AEDT| By Team Kalkine MediaHighlights:,Revenue grew by 17.5%,this,half-year.,Shift from a loss to a net profit.,Expansion through strategic acquisitions.,Regis Healthcare Limited (ASX:REG) delivered a compelling half-year performance ending 31 December 2024, reflecting a stron...
Perpetual Ends Talks with KKR, Plans Independent Sale of Wealth Management Unit
February 24, 2025 11:11 AM AEDT| By Team Kalkine MediaHighlights,Deal Terminated:,Perpetual ends talks with,KKR,for the sale of wealth management and corporate trust units.,Shareholder Interests:,An independent review found the,revised deal terms were not beneficial,to shareholders.,Sale Still on the Ta...
Monitor Cryosite as Insider Stock Sales Reach AU$8.3 Million
February 23, 2025 03:34 PM AEDT| By Team Kalkine MediaHighlights:,Cryosite Limited shares experienced a notable increase recently.,Insider transactions over the past year reflect more sales than purchases.,Insiders maintain a strong ownership presence in the company.,Cryosite Limited (ASX:CTE) operates...
Nanosonics Reports Strong Growth in First-Half Financial Results
February 23, 2025 03:32 PM AEDT| By Team Kalkine MediaHighlights:,Revenue Growth:,Nanosonics posted a significant increase in revenue, reflecting continued expansion in the medical equipment sector.,Profitability Gains:,The company achieved a notable rise in net income, supported by an improved profit m...
This Hearing-Aid Company is Well-Adapted to a Changing, Competitive Market
February 23, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Cochlear (ASX:COH) faces slowed sales of Nucleus 8 processors, prompting a strategic focus on innovation and market expansion.,The company sees promising growth opportunities in emerging markets and the adult and senior segments, despite e...
Health Check: Limited Visits to the GP as Patients Continue to Avoid Appointments Post-COVID
February 23, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Australian Clinical Labs (ASX:ACL),experiences fluctuations in GP and pathology visits, impacting financial outcomes.,EZZ Life Science (ASX:EZZ),expands its market presence with new product launches and broader distribution strategies.,Vit...
Vita Life Sciences Limited (ASX:VLS) Shares Need Better Earnings to Stabilize
February 22, 2025 11:39 AM AEDT| By Team Kalkine MediaHighlights:,Vita Life Sciences maintains a P/E ratio below many companies in the Australian market.,The company has demonstrated consistent earnings growth over multiple years.,Current market sentiment reflects a cautious stance despite strong financ...
Cogstate Limited Sees Notable Increase in Share Price Following Interim Results
February 22, 2025 11:37 AM AEDT| By Team Kalkine MediaHighlights:,Cogstate Limited's share price experienced a significant rise following interim financial results.,Revenue exceeded forecasts, leading to adjustments in earnings expectations.,Growth projections indicate a more moderate expansion compared...
Ecofibre Announces Earnings for the First Half of 2025
February 22, 2025 11:33 AM AEDT| By Team Kalkine MediaHighlights:,Revenue saw a slight decline from the previous year.,Net loss improved significantly over the period.,Share price experienced a recent downturn.,Ecofibre Limited (ASX:EOF) operates within the diversified industrials sector and has shared...
Dr. Boreham's Crucible: This Biotech Aiming to Address MSA Aspires to Be 'Distinctive'
February 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Alterity Therapeutics is progressing with clinical trials focused on addressing Multiple System Atrophy (MSA), a complex neurological disorder.,A successful funding initiative secured resources for ongoing research and clinical developmen...
Is Neurizon Therapeutics Facing Financial Pressure Amid Rising Cash Burn?
February 21, 2025 07:34 PM AEDT| By Team Kalkine MediaHighlights,Neurizon Therapeutics (ASX:NUZ) faces challenges due to increasing cash burn, affecting financial stability.,The company holds cash reserves but operates with a limited runway, requiring careful management.,Funding options may be explored,...
Can Steady Performance Sustain Future Growth in Healthcare?
February 21, 2025 07:30 PM AEDT| By Team Kalkine MediaHighlights:,Revenue and earnings align with market expectations.,Share price experienced a modest decline following the report release.,Growth trends remain consistent with the broader healthcare sector.,Operating within the healthcare services indus...
How Does Cosette's Acquisition of Mayne Pharma Reflect Current Market Dynamics in Australia?
February 21, 2025 06:38 PM AEDT| By Team Kalkine MediaHeadlines,• Australian shares display a downturn while technology entities enjoy a surge.,• A significant transaction sees Cosette acquiring Mayne Pharma in a deal valued at six hundred seventy‐two million Australian dollars.,• The arrangement unders...
What Are the Details Behind Opthea Limited's New ASX Quotation?
February 21, 2025 06:36 PM AEDT| By Team Kalkine MediaHeadlines,Update on the application for a new securities quotation on the Australian exchange,Issuance derived from the exercise of options and conversion of convertible instruments,Corporate structural adjustments unfolding within the healthcare and...
Telix Pharmaceuticals' (ASX:TLX) Shares Surge on Strong Full-Year Profit Growth
February 21, 2025 01:56 PM AEDT| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals (TLX) posts a tenfold increase in full-year profit.,The stock climbs over 13% following the announcement.,Shares have gained more than 170% over the past year.,Telix Pharmaceuticals (ASX:TLX) experienced a significant...
Mayne Pharma Backs $672 Million Takeover Offer from Cosette Pharma
February 21, 2025 01:51 PM AEDT| By Team Kalkine MediaHighlights,Mayne Pharma (,ASX:MYX,) receives a $7.40 per share acquisition offer from Cosette Pharma.,The deal,represents,a 37% premium to Mayne Pharma’s last closing price.,The acquisition expands Cosette Pharma’s portfolio and global presence in wo...
Telix Pharmaceuticals: Revenue Up 56%, Profit Jumps 860%, and More Growth Expected in FY 2025
February 21, 2025 11:13 AM AEDT| By Team Kalkine MediaKey Highlights:,Record High Share Price:,Telix shares hit,$30.00,, up,13%,on Friday morning.,Revenue Growth:,Revenue surged,56% to $783.2 million,, beating expectations.,Profit Explosion:,Profit after tax,soared 860% to $49.9 million,.,Strong FY 2025...
ASX Healthcare Sector: Market Resilience and Key Developments
February 21, 2025 11:00 AM AEDT| By Team Kalkine MediaASX Healthcare Sector: Market Resilience and Key Developments
Healius Navigates Turnaround Plan with Pathology Growth Amid Short-Term Challenges (ASX:HLS)
February 20, 2025 02:40 PM AEDT| By Team Kalkine MediaHighlights,Reports,$12.8 million net loss,amid business,restructuring,.,Revenue jumps 10%,to $933.9 million, with strong pathology growth.,Plans,special dividend,after debt refinancing.,Healius (ASX:HLS), Australia's second-largest pathology group, h...
Advertise your brand on Kalkine Media